RE
NVO icon

Rydar Equities’s Novo Nordisk NVO Stock Holding History

Rydar Equities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.5K Buy
+430
New +$19.8K 0.01% 271

Other funds holding NVO

Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Nichols & Pratt Advisers
Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
Cantor Fitzgerald Investment Advisors
Cantor Fitzgerald Investment Advisors New York $1.47B AUM 20.15% 1-Year Est. Return
PM
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return
San Luis Wealth Advisors
San Luis Wealth Advisors San Luis Obispo, California $660M AUM 11.72% 1-Year Est. Return
ERP
Eldred Rock Partners San Antonio, Texas $451M AUM 38.39% 1-Year Est. Return

Rydar Equities's NVO Position: Q3 2026 in Review

Rydar Equities opened a new position in Novo Nordisk (NVO) in Q3 2026: 430 shares worth $16.5K. The stake represents 0.01% of the portfolio and ranks #271 among its holdings.

218 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Rydar Equities held 430 shares of Novo Nordisk worth $16.5K as of Q3 2026.
  • Novo Nordisk was a new Rydar Equities position in Q3 2026.
  • Novo Nordisk made up 0.01% of Rydar Equities's portfolio in Q3 2026, its #271 holding.
  • 218 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.